The Immunex Alumni: Where Are They Now?

Margaret Summersgill, senior project manager, Amgen

Loni Syltebo, principal, Incline Marketing

Scott Taylor, senior scientist, Amgen

Dennis Thireault, project manager for business development and marketing analysis, PPD scientist, Hunan Youtell Biochemical

Doug Thompson Kisker, project manager, Seattle Biomedical Research Institute

Allison Torgesen, senior QC analyst, Seattle Genetics

Sandra Toussaint, office manager, PPD

Anne Trench, board member, Danica Children’s Foundation; Instructor, English for Parents, Atlantic Street Center [Added: 9 pm, 1/4/11]

Wayne Tsuji, associate clinical professor, University of Washington

Bob Ulrich, principal IS DBA, Amgen

Susan Ulrich-Angell, clinical trial associate I, Dendreon

David Urdal, executive vice president, chief scientific officer, Dendreon

Annette Vahratian, principal, AV Biopharma Consulting

Carol Vaisanen, senior consultant

Tim Vanden Bos, biotechnology professional

Gayle Van Mouwerik, senior project coordinator, Amgen

Kirk Van Ness, senior manager of preclinical development, AVI Biopharma

Moya Vazquez, biotechnology marketing consultant

William Villella, regional medical head, Novartis

Jo Viney, executive director of research, Amgen

G. Duke Virca, senior director of inflammation research, Amgen

Dawn Viveash, senior vice president, head of global quality, regulatory affairs, and safety, Orexigen Therapeutics

Wayne Wallis, principal, Dyad Life Science

Lee Wanke, independent pharmaceuticals professional

Susan Ware, business analyst, Boeing Commercial Airplanes

Tim Warner, communications executive

Steve Waugh, director of downstream process development, CMC Icos Biologics

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.